thermo fisher among bidders to acquire baxters biopharma unit – reuters.

exclusive-thermo fisher celltrion vie for baxters biopharma unit -sources. United States scientific instruments maker thermo fisher scientific inc and south koreas celltrion inc are among those competing to acquire the biopharma solutions busine

baxter international inc. shares close in on 52-week low - market mover. baxter international inc. (bax) shares closed today at 1.8% above its 52 week low of $38.31 giving the company a market cap of $20b. the stock is currently down 21.1% year-

baxter international inc. shares close in on 52-week low - market mover. baxter international inc. (bax) shares closed today at 1.8% above its 52 week low of $38.31 giving the company a market cap of $20b. the stock is currently down 21.1% year-

ex-dividend reminder: astrazeneca steris and baxter international. looking at the universe of stocks we cover at dividend channel on 2/23/23 astrazeneca plc (symbol: azn) steris plc (symbol: ste) and baxter international inc (symbol: bax) wi

baxter international (bax) lags q4 earnings estimates. baxter international (bax) came out with quarterly earnings of $0.88 per share missing the zacks consensus estimate of $0.94 per share. this compares to earnings of $1.04 per share

why baxter international stock is sinking today. what happened shares of baxter international (nyse: bax) were sinking 12.4% as of 12:18 p.m. et on thursday. the decline came after the company reported its 2022 full-year and fourth-quarter resu

baxter international enters oversold territory. the dividendrank formula at dividend channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two impo

baxter (bax) q4 earnings miss estimates fy23 outlook weak. baxter international inc. bax reported fourth-quarter 2022 adjusted earnings per share (eps) of 88 cents significantly missing the zacks consensus estimate of 94 cents. the bot

baxter issues fy23 guidance short of expectations says 5% layoffs will cut costs.

baxter international guides q1 fy23 adj. eps well below estimates. to cut 5% jobs - update. (rttnews) - while reporting financial results for the fourth quarter on thursday health care company baxter international inc. (bax) initiated earnings a

baxter non-gaap eps of $0.88 misses by $0.06 revenue of $3.9b beats by $130m initiates fy and q1 outlook.

baxter international inc. q4 profit decreases misses estimates. (rttnews) - baxter international inc. (bax) revealed a profit for fourth quarter that decreased from the same period last year and missed the street estimates.

wellington management group llp cuts stake in baxter international (bax). fintel reports that wellington management group llp has filed a 13g/a form with the sec disclosing ownership of 36.1

baxter international: another yoy earnings decline expected shares tag support.

earnings preview: baxter international (bax) q4 earnings expected to decline. the market expects baxter international (bax) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ende

baxter teams up with miromatrix for bioengineered liver.

baxter international becomes oversold. the dividendrank formula at dividend channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important cha

baxter (bax) plans to form standalone kidney care company. baxter international bax announced a comprehensive strategic roadmap to simplify its operating model and improve operating efficiencies. these strategic initiatives will also h

baxter plans divesting renal care business into separate public company shares fall.

friday sector laggards: healthcare services. the worst performing sector as of midday friday is the healthcare sector up 1.0%. within that group waters corp. (symbol: wat) and baxter international inc (symbol: bax) are two large stocks that

baxter to spinoff renal care business in restructuring plan.

baxter plans to spin off renal care and acute therapies global business units. (rttnews) - baxter international inc. (bax) said friday that it plans to spin off the renal care and acute therapies global business units into an independent publicl

becton upgraded. baxter downgraded as bofa shuffles medtech ratings.

: baxter international downgraded to neutral from buy at bofa securities. this is a real-time headline. these are breaking news delivered the minute it happens delivered ticker-tape style. visit www.marketwatch.com or the e page for more information about